Atıf Formatları
The use of recombinant human G-CSF in the treatment of propylthiouracil-induced agranulocytosis
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

H. A. ALTUNBAS Et Al. , "The use of recombinant human G-CSF in the treatment of propylthiouracil-induced agranulocytosis," INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.53, no.5, pp.396-397, 1999

ALTUNBAS, H. A. Et Al. 1999. The use of recombinant human G-CSF in the treatment of propylthiouracil-induced agranulocytosis. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.53, no.5 , 396-397.

ALTUNBAS, H. A., YAZICIOGLU, G., Balci, M. K., KARAYALCIN, U., & UNDAR, L., (1999). The use of recombinant human G-CSF in the treatment of propylthiouracil-induced agranulocytosis. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.53, no.5, 396-397.

ALTUNBAS, HASAN Et Al. "The use of recombinant human G-CSF in the treatment of propylthiouracil-induced agranulocytosis," INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.53, no.5, 396-397, 1999

ALTUNBAS, HASAN A. Et Al. "The use of recombinant human G-CSF in the treatment of propylthiouracil-induced agranulocytosis." INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.53, no.5, pp.396-397, 1999

ALTUNBAS, H. A. Et Al. (1999) . "The use of recombinant human G-CSF in the treatment of propylthiouracil-induced agranulocytosis." INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.53, no.5, pp.396-397.

@article{article, author={HASAN ALİ ALTUNBAŞ Et Al. }, title={The use of recombinant human G-CSF in the treatment of propylthiouracil-induced agranulocytosis}, journal={INTERNATIONAL JOURNAL OF CLINICAL PRACTICE}, year=1999, pages={396-397} }